Fig. 1. Endothelial precursors (angioblasts) in the embryo assemble in a primitive network (vasculogenesis), that expands and remodels (angiogenesis).
Smooth muscle cells cover endothelial cells during vascular myogenesis, and stabilize vessels during arteriogenesis. CL, collagen; EL, elastin; Fib, fibrillin. With permission from Ref. [4] .
outside of the embryo proper, on the yolk sac, as focal the center constitute hematopoietic precursors. The molecaggregations of mesenchymal cells, known as blood isular signals determining the fate of the hemangioblast are lands, form within the mesoderm adjacent to the exnot fully elucidated. However, several genes have been traembyronic endoderm. While the earliest studies sugidentified that may play a role in this early event [7] . These gested that the embryo proper becomes vascularized from include Ets-1 [8] , Hex [9] , Vezf [10] , Hox [11, 12] , branching and growth of extraembyronic blood vessels members of the GATA-family, basic helix-loop-helix which in turn are derived from fusion and channeling of (bHLH) factors [13, 14] , and the Id-proteins [15] . The blood islands, intraembryonic origins of a vascular netearliest markers common to endothelial and hematopoietic work were recognized as early as 1900 when it was precursors so far identified are CD31, CD34 and the determined that cells from isolated embryos were able to receptor tyrosine kinase type-2 of vascular endothelial cell give rise to blood vessels. It was at this time that the term growth factor (VEGFR-2 or KDR / Flk1) [16] . Inactivation angioblast, referring to the cells from which all endothelial of the VEGFR-2 gene in mice results in embryonic cells arise, was described. It was also during this early lethality, with lack of development of both hematopoietic period that the presence of the hemangioblast -a and endothelial cell lineages, supporting the critical imporcommon precursor for both endothelial cell and hematotance of this receptor at that developmental stage [17] , poietic cell -was first postulated (Fig. 2) . Notably, it was although not defining the steps regulating differentiation almost 100 years later that the presence of the hemangiointo endothelial versus hematopoietic cell. blast was confirmed [5] . Differentiation of pluripotent As the yolk sac vasculature begins to form |7.5 days embryonic precursor cells into hemangioblastic cells is post coitum (dpc) in the mouse, angioblasts that have induced to at least some extent by fibroblast growth factor migrated to the paraxial mesoderm assemble into aggre-(FGF) via protein kinase C signaling [6] . Hemangioblasts gates, proliferate and subsequently differentiate to form a undergo their first critical steps of differentiation within the plexus with endocardial tubes, leading to formation of the blood islands. Cells at the perimeter of the blood islands dorsal aortae, cardinal veins and the embryonic stems of give rise to precursors for endothelial cells, while those at yolk sac arteries and veins (Fig. 3) . Vasculogenesis was These include mesenchymal cells, neural crest cells, and progenitors in the epicardium in the embryo. Progenitors in the bone marrow and its stroma, and mesenchymal myofibroblasts also give rise to smooth muscle cells. A new common vascular progenitor cell that gives rise to both types of blood-vessel cell has been recently identified. Vascular endothelial growth factor (VEGF) promotes the development of endothelial cells from this precursor. TGF-b1 has been involved in differentiation of mesenchymal cells to progenitors, that express the receptor for PDGF-BB. The latter stimulates their development into smooth muscle cells and pericytes and is responsible for their recruitment around nascent vessels. Adapted from Ref. [114] .
originally believed to be restricted to embryonic developnatally [18, 22, 23] . Angioblast differentiation may be proment. However, it has been established that angioblasts not moted by VEGF, VEGFR2 and basic fibroblast growth only migrate intraembryonically, but may circulate postfactor (bFGF) [24] [25] [26] [27] , while VEGF receptor-1 (VEGFRnatally, and may be recruited for in situ vessel growth 1; Flt1) has been determined to suppress hemangioblast [18] [19] [20] (Fig. 4) . Unlike shed cells, circulating CD34 / commitment [28] . The findings that endothelial cells still VEGFR-2 /AC133-positive marrow-derived angioblasts in develop in mice engineered to lack VEGF but do not the adult have a high proliferation rate [21] . How angiobdevelop any longer in the absence of VEGFR-2, suggests lasts 'know' where and when to initiate vasculogenesis is that there are additional molecules, binding to VEGFR-2, largely a mystery, although a variety of growth factors and that determine endothelial cell fate. Although vasreceptors, including vascular endothelial growth factor culogenesis is closely linked to hematopoiesis, precursors (VEGF), granulocyte monocyte-colony stimulating factor of definitive hematopoietic cells arise only from the dorsal (GM-CSF) and other cytokines have been implicated, as aorta, and subsequently populate the liver, spleen and bone they have been shown to be able to recruit bone-marrow marrow. A basic understanding of the molecular mechaderived angioblasts to sites of neovascularization postnisms that separate hematopoiesis from vasculogenesis will not only impact on angiogenic therapies, but also on in tumors appears to be particularly complex, possibly treatment of a variety of hematologic disorders.
because the malignant cells derail the process via chaotic expression of angiogenic factors. As each of these steps is better elucidated, greater potential for therapeutic intervention will be forthcoming. 3. Angiogenesis 3.1. Existing vessels dilate, vascular permeability The molecular basis of angiogenesis is most easily increases and extracellular matrix is degraded characterized by viewing the process as a step-wise progression (Figs. 3 and 4) . The initial vasodilation of Largely in response to nitric oxide (NO), vasodilation is existing vessels is accompanied by increases in permeabilione of the earliest steps in angiogenesis. VEGF, transcripty and degradation of surrounding matrix, which allows tionally upregulated in part by NO [29] , mediates an activated and proliferating endothelial cells to migrate and increase in vascular permeability, accomplished through form lumens. The endothelial cells of these 'sprouting' redistribution of intercellular adhesion molecules, includnew vessels differentiate to accommodate local requireing platelet endothelial cell adhesion molecule (PECAM)-1 ments, supported by a surrounding network of similarly and vascular endothelial (VE)-cadherin, and alterations in differentiated peri-endothelial cells and matrix, all of cell membrane structure via induction of a series of kinases which mature through remodelling into a complex vascular [30, 31] . Extravasation of plasma proteins follows, similarnetwork, ultimately lined by endothelial cells that have ly induced by VEGF, these being required for creating a acquired critical survival factors, optimized to function temporary support structure, as activated endothelial cells under a variety of conditions. Our understanding of the subsequently migrate. Not surprising, excessive vascular cellular and molecular mechanisms in angiogenesis, in permeability could result in pathological outcomes, such as cancer and other diseases is still limited. Capillary growth intracranial hypertension or circulatory collapse. Conse- quently, permeability changes must be tightly regulated. inhibitors of MMPs include circulating protease inhibitors, Angiopoietin-1 (Ang1), a ligand for the endothelial resuch as tissue-localized inhibitors of metalloproteinases ceptor Tie2, is a natural anti-permeability factor, that (TIMPs) [35] . It is at least partly through the secretion of provides protection and a balance against excessive plasma MMP-2, MMP-3 and MMP-9, and suppression of TIMP-2 leakage [32] .
that Ang1 induces sprouting [36] . Similarly, MMPs 3, 7 Endothelial sprouting is further enhanced by another and 9 have been shown to induce angiogenesis in neonatal member of the angiopoietin family, Ang2, an inhibitor of bones and tumors [37] . Thrombospondin-1 (TSP-1) is believed to be anti-anof growth factors, including bFGF, VEGF and insulin-like giogenic by preventing activation of MMP-2 and MMP-9 growth factor-1 (IGF-1), which otherwise remain seques- [40] . Optimal angiogenic function of MMP-9 may require tered within the matrix. Over 20 matrix metalloproteinases cell-surface localization with the hyaluronan receptor (MMPs) have been described and implicated in angio-CD44 and TGF-beta [41] . Other proteinases have also been genesis, tumorigenesis and cell proliferation (reviewed in implicated in matrix degradation enabling endothelial cell Ref. [34] ). In addition, they can expose cryptic adhesion migration. Notably, urokinase-type plasminogen activator sites, hidden in non-proteolyzed matrix components. As (u-PA) is essential for revascularization of myocardial the name implies, MMPs play a central role in degrading infarcts [42, 43] , while antagonists of u-PA or its interaction extracellular membranes and basement membrane strucwith the u-PA have in vivo anti-angiogenic therapeutic tures, allowing endothelial migration to occur. Natural potential [43, 44] . A fine-tuned balance between proteinases and their inhibitors is, however, essential as excessive tion [60] . More recently, several chemokines, including plasmin proteolysis prevents pathological angiogenesis in monocyte chemotactic protein (MCP)-1, have been demcancer and inflammation [45] . This may also explain why onstrated to induce endothelial growth [61] . As the endothe u-PA inhibitor PAI-1 is a poor prognostic factor for thelial cells proliferate and migrate, directed in part by several cancers.
signaling through integrins a b and a b [62] , PECAM- [67, 68] . Integrins may endothelial cells are free to migrate to distant sites. At this localize MMPs to the endothelial cell surface and extracelstep, an interplay between the various forms of VEGF, lular matrix, thereby explaining why antagonists of integangiopoietins, FGFs and their receptors are responsible for rins might be therapeutically effective anti-angiogenic mediating embryonic, neonatal and pathological angioagents [69] . genesis, although additional factors have also been impliNumerous additional molecules with angiogenic or anticated in the process. There is likely considerable reangiogenic effects following administration in various dundancy -however, several distinct functions for many animal models, are currently being evaluated (Table 1) . of the components have been delineated. Although VEGF Those that are angiogenic are, among others, erythrohas profound effects throughout angiogenesis [46, 47] , poietin, insulin, IGF-1, neuropeptides, leptin, epidermal homologues of VEGF are more restricted. For example, growth factor, hepatocyte growth factor, interleukins, placental growth factor (PlGF) [48] is redundant for monocyte activating peptides, etc. [4, 70] . Similarly, natural embryonic vascular development, but an essential amplifier inhibitors of endothelial proliferation are being uncovered of VEGF-driven angiogenesis during pathological con- (Table 1 ). For instance, chondromodulin-1 is expressed in ditions (unpublished findings). VEGF-B has been implithe avascular zone of cartilage in developing bone, withcated in extracellular matrix degradation via activation of drawal of which results in capillary in-growth [71] . Some plasminogen, and is believed to regulate coronary artery of the endogenous angiogenesis inhibitors that are being function [49, 50] . VEGF-C has been demonstrated to stimuevaluated for clinical use include angiostatin [72], endolate angiogenesis in the adult, although its endogenous role statin [73] , anti-thrombin III, interferons, platelet factor-4, in pathology remains undefined [47] . Its receptor, VEGFRand others [4, 70] . The specific endogenous role of each of 3, is highly expressed during embryonic development, and these molecules during embryonic, post-natal and adult is required for vascular remodeling and angiogenesis vessel growth, remains largely unknown. [47, 51] . Ang1, via phosphorylation of Tie2, is chemotactic for endothelial cells, induces sprouting, and stimulates the 3.3. Endothelial cells assemble, form cords and acquire interaction between endothelial and peri-endothelial cells lumens [31, 52, 53] . Ang2, in concert with VEGF is also angiogenic, although in the absence of VEGF, Ang2 may As endothelial cells migrate into the extracellular maactually induce vessel regression [33] . trix, they assemble into solid cords, and subsequently Several additional factors have been implicated. Fiacquire a lumen. This is accomplished by intercalation and broblast growth factors stimulate endothelial cell growth thinning of the endothelial cells along with fusion of and recruit mesenchymal and / or inflammatory cells, existing vessels to create longer and greater diameter producing a myriad of angiogenic factors [54] . Plateletvessels. Tumor vessels are structurally and functionally derived growth factor (PDGF) is angiogenic for miabnormal. They are highly disorganized: vessels are tortucrovascular sprouting endothelial cells and recruits ous and dilated, with uneven diameter. They have excespericytes and smooth muscle cells around nascent vessel sive branching and shunts. This may be due to an sprouts [55, 56] . From gene inactivation studies in mice, imbalance of angiogenic regulators, such as VEGF and endothelial nitric oxide synthase (eNOS) was determined angiopoietins, or alternatively, due to different molecular to have in vivo angiogenic properties, inducing endothelial signals. Consequently, the blood flow in tumors is chaotic, growth following denudation injury or hind limb ischemia changing from one location to the next and from one time [57] . Additional studies have demonstrated that VEGF to the next [74] . Lumen diameter is tightly regulated by stimulates eNOS and release of NO. Members of the several factors. While VEGF and VEGF and their 121 165 TGFb superfamily, such as activin A and tumor necrosis receptors increase lumen formation, VEGF decreases 189 factor (TNF)-a, are multifunctional cytokines that have lumen diameter. In combination with VEGF, Ang1 augbeen variably reported to both stimulate and inhibit ments lumen diameter [52] . Multiple integrins (a b and 5 1 endothelial growth in different models [58] . TGF-b1 a b ) are also involved in lumen formation and cyclic v 3 suppresses tumor angiogenesis [59] , while TNF-a was RGD compounds may abrogate their function, another recently reported to modulate VEGF induced endothelial potential for therapeutic intervention [75] . Finally, there proliferation via interference with VEGFR-2 phosphorylaare also several endogenous inhibitors of lumen formation, including thrombospondin-1 (TSP-1), and a recently idenwhich in the retina or ovary after birth, is a natural and tified novel gene, tubedown (tbdn)-1, that has homology to physiologic process. The list of factors identified that acetyltransferases [76] . Ultimate selection of factors reregulate endothelial apoptosis is extensive [78, 79] , and sponsible for specific regulation of tumor angiogenesis is a these vary considerably according to the developmental major focus of current research.
time point, the specific site, function and type of vessel, in addition to surrounding physiological and / or pathological 3.4. Long-term survival of vascular endothelium stimuli. The molecular mechanisms by which a 'quiescent', confluent endothelium is able to maintain its physioOnce new vessels have assembled, the endothelial cells logical function in various vascular beds for long periods become remarkably resistant to exogenous factors, and are of time, is unclear. However, some insights have been quiescent, with survival measured in years. Diminished gained from in vivo and in vitro studies. Deprivation of endothelial survival -or endothelial apoptosis -is nutrients following obstruction of vessels by spasm or characterized by vascular regression in the embryo [77] , thrombi, results in release of pro-apoptotic signals and effective suppression of anti-apoptotic stimuli, leading to participate in monoctye transmigration and regulation of endothelial programmed cell death and vessel regression.
permeability [87, 88] . In contrast, endothelial cells in In premature babies, exposure to hyperoxia reduces VEGF endocrine glands lack the tight junctions of the bloodlevels and causes retinal vessel regression [80, 81] . The role brain barrier. Rather, the endothelium is discontinuous and of VEGF as a survival factor depends on its interaction fenestrated, allowing high-volume molecular and ion transwith VEGFR-2, PI3-kinase, b-catenin and VE-cadherin port. Overall, the factors that regulate acquisition of [77] . Lack of the cytoplasmic domain of VE-cadherin specific endothelial properties are largely unknown. Howresults in endothelial apoptosis via interruption of VEGF ever, it appears that the host environment, in concert with signalling, leading to diminished activation of the protein VEGF, plays a major role [89, 90] . Endothelial differentiakinase Akt and lack of upregulation of the anti-apoptotic tion in tumors is abnormal and results in vessels with bcl-2 gene [77] . While the endothelial survival function of multi-layered endothelium, irregularly sized lumens, and VEGF is evident in the embryo, adult quiescent vessels non-uniform junctional complexes that tend to be highly appear to be less sensitive to VEGF deprival.
permeable [70] . Recent findings suggest that tumor vessels Other factors known to play a role in endothelial may be lined not only by endothelial cells, but by tumor survival include the angiopoietins via their cognate recells themselves which have attained 'vasculogenic' propceptors, Tie1 and Tie2 -Ang 1 promotes, while Ang2 erties or a mosaic of cancer and endothelial cells [91] . For suppresses survival, particularly with respect to tumor example, 15% of vessels in xenografted and spontaneous vessel growth [31, 52, 82] . Ang1 has further been deterhuman colon carcinomas are mosaic in nature [92] . Somined to exert survival properties by enhancing expression called 'vasculogenic mimicry', which implies de novo of the anti-apoptotic gene, survivin, via activation of Akt generation of vasculature without participation of endothrough Tie2 signalling [83] . Maintenance of vascular thelial cells and independent of angiogenesis, would have a integrity in different vascular beds also requires hemomajor impact on therapy designed to interfere with new dynamic shear forces, which not only provide appropriate vessel growth associated with tumorigenesis [93] . metabolic requirements to target tissues, but regulate and reduce endothelial turnover and abrogate endothelial apop-
Remodeling of vessels yields complex, functional tosis caused by TNF-a [84]. Molecular mechanisms implinetworks cated in mediating cell cycle arrest and survival of vascular endothelial cells include several factors involved in regula-
The three-dimensional organization of the vascular tion of cell-cycle and apoptosis, such as p53, p21, p16, network has fascinated many scientists for a long time p27, Bax and p42 / 44 mitogen activated protein kinase [54] . One of the first was Aristotle, who wrote: ''the [85]. Many other angiogenesis inhibitors provide survival system of blood vessels in the body may be compared to advantages to endothelium, however the mechanisms of those of water-courses which are constructed in gardens: action are similarly unknown. Examples include prothromthey start from one source, or spring, and branch off into bin kringles-1 and -2, thrombospondin-2, antagonists of numerous channels, and then into still more, and so on PECAM-1, interleukins 4 and 12, and cyclo-oxygenase-2 progressively, so as to carry a supply to every part of the (Cox) inhibitors.
garden''. Several mechanisms have been identified that could result in the branching of vessels. First, new vessel 3.5. Vascular endothelium differentiates to meet local branches can sprout towards a cluster of cells in the needs surrounding mesenchyme, that produce the angiogenic stimulus. Second, vessels can split into individual daughter With maturation of the vascular network, local physiovessels by the formation of transendothelial cell bridges. logical requirements must be met. To this end, endothelial Third, vessels can branch via intussusception, based upon cells acquire highly specialized characteristics to provide insertion of interstitial tissue columns into the lumen of the functional needs within specific tissues and organs. For pre-existing vessels [94, 95] . The subsequent growth of example, development of the blood-brain barrier requires these columns and their stabilization -in part via interactions between astroglial cells that express glial ingrowth of periendothelial cells -results in partitioning fibrillary acidic protein, pericytes and adequate angiotenof the vessel lumen and remodeling of the vascular sinogen levels [55] . The tight junctional complex between network. endothelial cells consists of numerous integral membrane A number of angiogenic signals have been identified to and cytosolic proteins from, for example, the families of affect one or more of these branching processes, although cadherins, occludins, claudins, and membrane-associated the distinction between these processes is often blurred guanylate kinase homologous proteins [86, 87] . The plasma [96] . For the sake of clarity and brevity, some typical membranes of those endothelial cells reaching confluence examples are illustrated. VEGF contributes to the complexnecessarily undergo major structural and functional modiity of the vascular network by stimulating vascular splitfications, crucial for the regulation of vascular permeabiliting and sprouting [97] . Embryos lacking a single VEGF ty. Other proteins, such as 7H6, cingulin and JAM allele have fewer vascular sprouts [25, 26] . In addition, mice that only express the short VEGF isoform die of largely unknown. Basic helix-loop-helix (bHLH) transcrip-120 ischemic heart disease and suffer a markedly reduced tion factors often determine cell fate and differentiation, coronary perfusion reserve [98] . This resulted from a including that of endothelial cells [7] . Recently, the bHLHsignificantly impaired branching of myocardial vessels.
transcription factor gridlock was identified to determine Expression of PDGF-BB, which is known to affect airway arterial specification [104] . A common angioblast may branching, was reduced in these hearts, but it is also give rise to pre-venous and pre-arterial angioblastspossible that VEGF also acts as a 'branching factor' by gridlock would favor differentiation of pre-arterial at the directly affecting endothelial and / or smooth muscle cells.
expense of pre-venous angioblasts (Fig. 2) . Notch sigAng1 and its receptor Tie2 induce angiogenic sprouts, but naling is associated with cell fate determination via lateral may also affect microvascular intussusceptive growth [31] . specification and inductive signaling between distinct cell Indeed, gene inactivation of Ang1 and Tie2 resulted in types. Cerebral autosomal dominant arteriopathy with dilated capillary-like vessels of uniform size that fail to subcortical infarcts and leukoencephaly (CADASIL) is a remodel in a mature, complex network of large vessels late onset vascular disease, caused by a mutation in the ramifying into smaller branches. Renin is a 'branching Notch3 gene. Recent evidence indicates that Delta4, a factor' for renal arteries [99] , while acidic FGF is a Notch ligand, is expressed in arterial endothelium [105] 'branching factor' for myocardial arteries [100] . Such a and that defective Notch signaling caused vascular rerole of FGF-1 in the vasculature is consistent with the role modeling defects [102, 103] . The hairy-related bHLH factor of the FGF-related signals in airway branching. Notch
HeyL, an effector of Notch, is expressed in smooth muscle signaling has been implicated in the singling-out process of of all arteries, overlapping with that of Notch3, mutations budding airway cells. Indeed, the FGF-like branchless of which underlie the CADASIL vascular disorder [106] . upregulates expression of Delta, a ligand for Notch, at the There is mounting evidence to indicate that members of tip of the tracheal branches. Activated Notch then restricts the large ephrin family may play a role. Ephrins are the branchless-signal to the tip of the branches by dowligands for their corresponding Eph receptors, the latter nregulation of branchless in neighboring cells via lateral forming a family of at least 14 receptor tyrosine kinases inhibition. A challenge for the future will be to unravel [31, 66] . Ephrins must be membrane bound to activate their whether FGF-1 also induces a similar finely tuned cascade receptors. Ephrin A1 (or B61) and ephrin A2 are anof cellular and molecular events in the heart as branchless giogenic, with specificity based on vascular bed [107] . and FGF-10 accomplish in the lung. For instance, it Ephrins B1 and B2 induce sprouting. Ephrin B2 is remains to be determined whether Notch, Delta, and restricted to arteries, whereas its receptor, EphB4 is found Jagged [101] -molecules of which we only now start to in veins -not arteries [108] . Inactivation of the ephrin B2 reveal their role in angiogenesis [102, 103] -are also gene in mice results in normal vasculogenesis but abnorinvolved in singling out sprouting endothelial cells via mal angiogenesis, the latter with disrupted remodeling of lateral inhibition in response to FGF-1.
both arteries and veins into large and small branches, and Several gene targeting studies implicate other factors in diminished vessel maturation with decreased association of vessel patterning and remodeling, including VEGFR-3, the peri-endothelium [109, 110] . Complex ligand-receptor endothelial receptor Tie1, T-cell leukemia protein stem cell bidirectional signalling interactions via ephrins and ephrin leukemia factor / tal-1, members of the Ets family of receptors have been described, with responses dependent transcription factors, some GTP-binding factors, VCAM-1, on a variety of factors, including phosphorylation, multia integrin and fibronectin which all have distinct roles in merization, and the presence of adaptor proteins, such as 4 the patterning of the vasculature during development Grb2, Grb10 and Nck. A novel cytoplasmic tyrosine kinase (reviewed in Ref. [4] ). In several diseases, vessels do not gene, bone marrow tyrosine kinase (Bmx), was identified grow, but primarily remodel. For instance, skin vessels in arterial endothelium [111] . Future studies will be enlarge in psoriasis or vascular malformations, preexisting required to unravel the differentiation characteristics of collaterals in the heart or peripheral limbs expand more veins, arteries and capillaries [112] . than 20-fold after arterial occlusion, and pulmonary vessels become invested by smooth muscle cells during pulmonary 3.8. Critical role of peri-endothelial cells and hypertension (see below). For effective, targeted ansurrounding matrix giogenic therapy, insights into the complex means by which correct patterning can be effected in different
Although the endothelium has received the most attentissues, will be invaluable. tion in angiogenesis research, the surrounding peri-endothelial cell layers and extracellular matrix are critical for 3.7. Vein or artery?
ongoing structural and functional support of the vascular network. Vascular smooth muscle cells stabilize nascent Interestingly, the molecular signals determining which vessels by inhibiting endothelial proliferation and migraendothelial and peri-endothelial cells will belong to an tion. Indeed, vessels regress more easily when not covered artery, which to a vein, and which to a capillary, are by smooth muscle cells in case angiogenic stimuli become limiting [56, 113] . Furthermore, peri-endothelial cells are role in peri-endothelial cell recruitment and growth. For metabolically active, and express a variety of vasoactive example, endothelin-1 is chemotactic for neural crest cells peptides, growth factors and cytokines that impact on the and transforms these into smooth muscle cells in the overall function of the vasculature. The extracellular thoracic vasculature. Tissue factor promotes pericyte rematrix is also critical for normal vessel growth and cruitment, possibly through initiation of coagulation and maintenance, by providing not only a 'solid' scaffold generation of thrombin. Ephrin-Eph ligand-receptor interthrough which new vessels may migrate, but to store and actions may also transfer signals between endothelium and mobilize necessary growth factors, to mediate appropriate mesenchymal cells [31] . The basic helix-loop-helix tranintercellular signals. Overall, an understanding of the scription factor, dHAND, is required for normal reciprocal means by which peri-endothelial cells are recruited to and interaction between vascular mesenchymal cells and endoencase the endothelial tubes, differentiate to serve a local thelial cells, as well as smooth muscle cell differentiation. function, and finally interface with the extracellular matrix Lack of dHAND in mice results in severe vascular and endothelium, is essential to ultimately designing abnormalities during development, with consequent lethaliangiogenic therapies.
ty [121] . Finally, adhesion molecules such as N-cadherin, The origin of smooth muscle cells is a subject of further provide more 'permanent' connections between considerable research, with still many unanswered quesendothelium and mesenchymal cells. tions [114] (Fig. 2) vessels, a not infrequent site of congenital malformations mediates attachment to collagen, is essential for vessel [116] . Recently, a novel common vascular progenitor has survival and maturation of blood vessels during angiobeen identified that gives rise to endothelial cells upon genesis, and inhibition of this interaction result in apopexposure to VEGF and to smooth muscle cells when tosis of endothelium, vessel regression, and interference of treated with PDGF-BB [117] . Similarly to vascular smooth the angiogenic effects of VEGF and TGFb [122, 123] . muscle cells, pericytes covering arterioles, venules and
Other matrix components include fibronectin, laminin, capillaries serve multiple functions, modulating blood flow vitronectin, osteopontin, fibrin, hyaluronic acid, and thromand vascular permeability, regulating growth of blood bospondin, each of which variably interacts with integrins vessels, and providing signals to endothelium and matrix and other growth factors, facilitating endothelial and perivia secreted and cellular molecules [118] .
endothelial cell migration, tube formation and vascular Recruitment of peri-endothelial cells is mediated by an network maturation. array of local factors (Fig. 3) . PDGF-BB is chemoattractant for smooth muscle cells [55] , while VEGF, possibly 3.9. Arteriogenesis via release of PDGF or binding to VEGF receptors, also contributes. Interactions between the endothelial cells of Once the peri-endothelial cells are recruited, they connascent vessels and the peri-endothelial cells are stabilized tinue to migrate along sprouting vessels or pre-existing by Ang1 and Tie2, the latter of which also induces vasculature (Fig. 1) . PDGF-BB plays an essential role in branching and remodeling [31, 53, 55] . There is strong this process -at least in organs where peri-endothelial clinical evidence of the importance of these receptor-ligand cells are not recruited from the local mesenchyme [56] . systems in vessel maturation. Dysfunction of Tie2 results
Although the cues regulating the spatial organization are in diminished smooth muscle cells and vascular malformanot yet delineated, there are definite patterns of peritions in humans. Members of the TGF-b family, including endothelial cell migration as exemplified in the heart, TGF-b1, TGF-b receptor-2, endoglin and Smad5, also where smooth muscle cell coverage proceeds in an epicarwork in concert to induce vessel maturation by stimulating dial to endocardial direction. Depending on the vessel type smooth muscle cell differentiation and extracellular matrix and site, additional smooth muscle cell layers are added, as deposition, while inhibiting endothelial proliferation and the cells proliferate, differentiate and thereby acquire migration. Patients who lack endoglin have a prominent specialized functions, including contractility. In this revascular bleeding disorder -hereditary hemorrhagic spect, a number of receptors are expressed that respond to telangiectasia -characterized by vascular malformations hormones, neuromodulators, and other effector molecules [119] . Mice lacking endoglin die in utero of vascular that are necessary to maintain appropriate tone and funcabnormalities due to poor vascular smooth muscle cell tion under different physiological and pathological condevelopment and arrested endothelial remodeling [120] .
ditions. Interstitial matrix components, such as elastin and There are several other molecules that reportedly play a fibrillin-2, provide arteries with viscoelastic properties, while collagen and fibrillin-1 add structural strength. contain a consensus hypoxia responsive element (HRE) in Several defects in arteriogenesis have been described. the 59 promoter region of the target genes with which HIF Inactivation of the gene encoding the transcription factor associates [131] . HIF-1a is itself induced by hypoxia, MEF2C results in an embryonic lethal phenotype in which while the subunit HIF-1b is constitutively expressed. the severe vascular disorder is characterized by lack of During normoxia, the product of the gene responsible for differentiation of vascular smooth muscle cells [124] .
von Hippel Lindau disease, VHL, targets HIF-1a for rapid Deficiency of fibrillin-1 in mice recapitulates the vascular degradation [132] . During hypoxia, however, HIF-1a is defects of Marfan syndrome in humans, characterized by stabilized [132] . Inactivation of the HIF-1a or HIF-1b weakening and aneurysmal dilatation of the arteries [125] .
genes in mice supports a role for hypoxia in regulating Elastin both regulates smooth muscle proliferation and angiogenesis rather than vasculogenesis [133, 134] . Of stabilizes arterial structure. Elastin deficiency leads to potential therapeutic impact is the finding that blood vessel obstructive intimal hyperplasia with features similar to formation is reduced in tumors that lack either HIF-1a or those found in atherosclerosis [126] .
HIF-1b [135] [136] [137] . Further delineating the molecular Inflammatory cells have been implicated in the growth regulation of VEGF and other angiogenic molecules via of pre-existing collateral arterioles after occlusion of a hypoxia inducible factor, hypoxia responsive elements, and supply artery in the myocardium and peripheral limbs in turn, the means by which these are functionally stabi- [127, 128] (Fig. 4) . This process has been termed 'adaptive lized or degraded by, for example, VHL, will lead hopefularteriogenesis' to distinguish the distinct cellular and ly to more effective angiogenic and anti-angiogenic treatmolecular mechanisms from those in true angiogenesis ment approaches to disease. (capillary growth). As a result of the increased collateral flow, endothelial cells express chemokines (MCP-1) and 3.11. Shear stress and vascular remodeling adhesion molecules (ICAM-1). The recruited monocytes infiltrate and proteolytically remodel the vessel wall [127] .
Although oxygen tensions in different vascular beds Activated endothelial cells then upregulate bFGF, PDGF-B have profound effects on vascular development and and TGF-b1, which stimulate smooth muscle cell growth growth, other factors have also been implicated in regulatand vessel enlargement. It is possible that flow provides ing both VEGF expression and angiogenesis. There is the necessary survival signals for maintenance of collaterconsiderable evidence to show that blood flow shear als. Adaptive arteriogenesis finally results in functional and stresses and blood pressure affect vascular remodeling and structurally normal arteries, which ameliorate the detrithe development of collateral circulation both under physmental effects of vessel obstruction [128] . These vessels iological and pathological conditions [138] . As with hypomay be superior to newly formed capillaries (formed by xia, vasculogenesis appears to proceed unaffected by these angiogenesis), because they are able to sustain proper factors. During development, smooth muscle cell covering circulation and to adapt to changes in physiological of coronary vessels is spatio-temporally related to the demands of blood supply. Therefore, we should critically generation of adequate capillary pressure proximal to the consider whether therapeutic stimulation of new blood aorta, a process that may lead to the differentiation of vessels in ischemic tissues should be aimed at improving arteries from veins. Shear stress has profound effects on angiogenesis or, perhaps preferably, arteriogenesis. the functional expression of many endothelial and smooth muscle cell proteins, including transcription factors such as 3.10. Oxygen levels regulate vessel growth and c-Fos and Egr-1, enzymes such as angiotensin converting remodeling enzyme and nitric oxide synthase, growth factors including PDGF-A and B, and TGF-b, and finally several signaling The role of oxygen tension in regulating VEGF levels is molecules, integrins and adhesion molecules -an array of critical to its function as an angiogenic factor. Accumulacomplex interactions that result in vascular remodelling tion of VEGF mRNA is induced by exposure to low under a variety of conditions. Further insights into the oxygen levels both in vitro and in vivo [129] . Not specific roles of many of these molecules have been surprisingly, many other genes directly or indirectly inprovided by gene-targeting studies in mice [139, 140] . volved in angiogenesis, are also upregulated in response to hypoxia. These include, among others, the VEGF receptors VEGF-R1, VEGF-R2, neuropilin-1, neuropilin-2, Ang2, 4. Summary nitric oxide synthase, TGFb1, PDGF-BB, endothelin-1 and IL-8 [130] . A transcriptional complex, composed of hypo-
The basic molecular mechanisms governing how endoxia inducible factors (HIF) -HIF-1a, HIF-1b (aryl thelial cells, peri-endothelial cells and matrix molecules hydrocarbon receptor nuclear translocator; ARNT) and interact with each other and with numerous growth factors HIF-2a -serve to augment expression of several of the and receptors, to form blood vessels have been presented. genes involved in angiogenesis and cell survival. Some of The many insights gained from this basic knowledge are those, including VEGF, erythropoietin and VEGFR-1 being extended to further understand pathological angio- 
